<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01927354</url>
  </required_header>
  <id_info>
    <org_study_id>201112085RID</org_study_id>
    <nct_id>NCT01927354</nct_id>
  </id_info>
  <brief_title>Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.</brief_title>
  <official_title>Observational Study on the Investigation of the Molecular Mechanism and Clinical Significance of the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the molecular mechanism and clinical significance of the interplay between
      Twist1 and other EMT regulators through microRNA-29 family.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Head and neck squamous cell carcinoma (HNSCC) is one of the leading causes of cancer deaths
      worldwide, and it ranks the fourth male cancer-related death in Taiwan. In HNSCC,
      invasiveness and metastasis of cancer cells contribute to the major cause of mortality;
      therefore, elucidation of the mechanism and development of new strategies against metastasis
      is the utmost importance in treating advanced HNSCC. Epithelial-mesenchymal transition (EMT)
      is a process by which epithelial cells lose their polarity and are converted to a mesenchymal
      phenotype, and recently is considered as the major mechanism for cancer metastasis. The
      initiation of EMT is hallmarked by suppression of the intercellular junctional protein
      E-cadherin by a variety of transcriptional factors, including Twist1, Snail, Slug, SIP1, Zeb1
      and E47. However, during metastatic evolution, the interplay between different EMT inducers
      has been investigated limitedly. Previously study demonstrated that hypoxia induces EMT of
      HNSCC through induction of Twist1 expression. Additionally showed that Twist1 promotes EMT
      and tumor-initiating capability through upregulation of Bmi1, and co-expression Twist1 and
      Bmi1 predicts a worse prognosis of HNSCC cases. Accumulated evidence suggests that microRNAs
      play essential roles in cancer progression and metastasis. Therefore, we aim to investigate
      the role of microRNA in Twist1-mediated cancer metastasis, and the interplay between Twist1
      and other EMT regulators. Our preliminary data showed that the expression of miR-29 family,
      including miR-29a, b, and c were increased in Twist1-overexpressing HNSCC cells. Furthermore,
      we discovered that SIN3A, a co-repressor of another EMT regulator Snail, is a target of
      miR-29s. We therefore speculate that Twist1 modifies the function of Snail through microRNA
      machinery. In this proposal, we will delineate the regulatory mechanism of the
      Twist1-miR29s-SIN3A axis. We will also investigate the molecular interplay between Twist1 and
      Snail through Twist1-miR29s-SIN3A signal pathway. Furthermore, we will elucidate the
      molecular basis and pathophysiologic significance of Twist1-Snail interaction under hypoxic
      environment. Finally, we will confirm the in vitro finding by in vivo animal study and HNSCC
      samples. These results will provide crucial information for understanding the molecular basis
      of HNSCC metastasis, and will be valuable for developing new therapeutic strategies against
      advanced HNSCC.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>The interplay between Twist1 and other EMT regulators throigh microRNA-29 family</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Head-and-Neck Squamous Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Head and neck cancer</arm_group_label>
    <description>Subjects who suffer from oral cancer. Collect a 0.5x0.5Cm2 tissue sample of the tumor during the surgery.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Medical center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Head and neck cancer

        Exclusion Criteria:

          -  pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shin-Jung Cheng, DDS, MS, PhD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Shin-Jung Cheng, DDS, MS, PhD</last_name>
    <phone>+886 2 29251733</phone>
    <phone_ext>67509</phone_ext>
    <email>sjcheng56@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital research Ethics Committee</name>
      <address>
        <city>Taipei</city>
        <zip>10048</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shin-Jung Cheng, DDS, MS, PhD</last_name>
      <phone>+886 2 29251733</phone>
      <phone_ext>67509</phone_ext>
      <email>sjcheng56@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Shin-Jung Cheng, DDS, MS, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Department of health, the Executive Yuan, R.O.C. Cancer Registry Annual Report in Taiwan area, 2007. Goldenberg D, Lee J, Koch WM, et al.</citation>
  </reference>
  <reference>
    <citation>Goldenberg D, Lee J, Koch WM, Kim MM, Trink B, Sidransky D, Moon CS. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg. 2004 Dec;131(6):986-93. Review.</citation>
    <PMID>15577802</PMID>
  </reference>
  <reference>
    <citation>Haffty BG. Concurrent chemoradiation in the treatment of head and neck cancer. Hematol Oncol Clin North Am. 1999 Aug;13(4):719-42, vi-vii. Review.</citation>
    <PMID>10494509</PMID>
  </reference>
  <reference>
    <citation>Gilbert J, Forastiere AA. Organ preservation trials for laryngeal cancer. Otolaryngol Clin North Am. 2002 Oct;35(5):1035-54, vi. Review.</citation>
    <PMID>12587246</PMID>
  </reference>
  <reference>
    <citation>Fanucchi M, Khuri FR. Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 2004 Dec;31(6):809-15. Review.</citation>
    <PMID>15599859</PMID>
  </reference>
  <reference>
    <citation>Papadimitrakopoulou VA, Izzo J, Mao L, Keck J, Hamilton D, Shin DM, El-Naggar A, den Hollander P, Liu D, Hittelman WN, Hong WK. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clin Cancer Res. 2001 Oct;7(10):3127-34.</citation>
    <PMID>11595705</PMID>
  </reference>
  <reference>
    <citation>Farrar M, Sandison A, Peston D, Gailani M. Immunocytochemical analysis of AE1/AE3, CK 14, Ki-67 and p53 expression in benign, premalignant and malignant oral tissue to establish putative markers for progression of oral carcinoma. Br J Biomed Sci. 2004;61(3):117-24.</citation>
    <PMID>15462255</PMID>
  </reference>
  <reference>
    <citation>Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer. 2009 Mar 1;115(5):922-35. doi: 10.1002/cncr.24123. Review.</citation>
    <PMID>19156911</PMID>
  </reference>
  <reference>
    <citation>Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res. 2004 Sep 1;10(17):5820-7.</citation>
    <PMID>15355912</PMID>
  </reference>
  <reference>
    <citation>Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer. 2001 Dec 15;92(12):3037-44.</citation>
    <PMID>11753981</PMID>
  </reference>
  <reference>
    <citation>Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002 Jun;2(6):442-54. Review.</citation>
    <PMID>12189386</PMID>
  </reference>
  <reference>
    <citation>Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007 Dec;117(12):3810-20.</citation>
    <PMID>18037992</PMID>
  </reference>
  <reference>
    <citation>Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995. Review.</citation>
    <PMID>16024595</PMID>
  </reference>
  <reference>
    <citation>Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42. Review.</citation>
    <PMID>16493418</PMID>
  </reference>
  <reference>
    <citation>Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 2000 Apr 5;92(7):569-73.</citation>
    <PMID>10749913</PMID>
  </reference>
  <reference>
    <citation>Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 2004 Jan;24(1):306-19.</citation>
    <PMID>14673164</PMID>
  </reference>
  <reference>
    <citation>Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, Nieto MA. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002 May 9;21(20):3241-6.</citation>
    <PMID>12082640</PMID>
  </reference>
  <reference>
    <citation>Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005 Apr 15;103(8):1631-43.</citation>
    <PMID>15742334</PMID>
  </reference>
  <reference>
    <citation>Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Lin SB, Liou GY, Lee ML, Chen JJ, Hong TM, Yang SC, Su JL, Lee YC, Yang PC. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res. 2005 Nov 15;11(22):8070-8.</citation>
    <PMID>16299238</PMID>
  </reference>
  <reference>
    <citation>Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Höfler H, Becker KF. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002 Nov;161(5):1881-91.</citation>
    <PMID>12414534</PMID>
  </reference>
  <reference>
    <citation>Peña C, García JM, García V, Silva J, Domínguez G, Rodríguez R, Maximiano C, García de Herreros A, Muñoz A, Bonilla F. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer. 2006 Nov 1;119(9):2098-104.</citation>
    <PMID>16804902</PMID>
  </reference>
  <reference>
    <citation>Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006 Nov 17;127(4):679-95. Review.</citation>
    <PMID>17110329</PMID>
  </reference>
  <reference>
    <citation>Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002 Jan;2(1):38-47. Review.</citation>
    <PMID>11902584</PMID>
  </reference>
  <reference>
    <citation>Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8(4 Suppl):S62-7. Review.</citation>
    <PMID>11927290</PMID>
  </reference>
  <reference>
    <citation>Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007 Jun;7(6):415-28. Epub 2007 May 17. Review.</citation>
    <PMID>17508028</PMID>
  </reference>
  <reference>
    <citation>Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T, Konishi I. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol. 2003 Oct;163(4):1437-47.</citation>
    <PMID>14507651</PMID>
  </reference>
  <reference>
    <citation>Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH, Semenza GL. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 2006 Mar 1;66(5):2725-31.</citation>
    <PMID>16510593</PMID>
  </reference>
  <reference>
    <citation>Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, Sufan RI, Roberts AM, Wilson LA, Betten M, Vandewalle C, Berx G, Marsden PA, Irwin MS, Teh BT, Jewett MA, Ohh M. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol. 2007 Jan;27(1):157-69. Epub 2006 Oct 23.</citation>
    <PMID>17060462</PMID>
  </reference>
  <reference>
    <citation>Ip YT, Park RE, Kosman D, Yazdanbakhsh K, Levine M. dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev. 1992 Aug;6(8):1518-30.</citation>
    <PMID>1644293</PMID>
  </reference>
  <reference>
    <citation>Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009 Nov;50(5):1464-74. doi: 10.1002/hep.23221.</citation>
    <PMID>19821482</PMID>
  </reference>
  <reference>
    <citation>Ogawa H, Nozawa Y, Rojanavanich V, Tsuboi R, Yoshiike T, Banno Y, Takahashi M, Nombela C, Herreros E, Garcia-Saez MI, et al. Fungal enzymes in the pathogenesis of fungal infections. J Med Vet Mycol. 1992;30 Suppl 1:189-96. Review.</citation>
    <PMID>1474443</PMID>
  </reference>
  <reference>
    <citation>Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004. Epub 2004 Feb 18.</citation>
    <PMID>14973191</PMID>
  </reference>
  <reference>
    <citation>Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005 Jun 9;435(7043):834-8.</citation>
    <PMID>15944708</PMID>
  </reference>
  <reference>
    <citation>Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.</citation>
    <PMID>18376396</PMID>
  </reference>
  <reference>
    <citation>Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008 Nov;28(22):6773-84. doi: 10.1128/MCB.00941-08. Epub 2008 Sep 15.</citation>
    <PMID>18794355</PMID>
  </reference>
  <reference>
    <citation>Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047. Retraction in: Cell. 2015 Apr 9;161(2):417.</citation>
    <PMID>19524507</PMID>
  </reference>
  <reference>
    <citation>Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB, Liu M, Zou Y, Weissman IL, Gu H. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med. 2010 Mar 15;207(3):475-89. doi: 10.1084/jem.20090831. Epub 2010 Mar 8.</citation>
    <PMID>20212066</PMID>
  </reference>
  <reference>
    <citation>Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009 Apr;10(4):400-5. doi: 10.1038/embor.2009.9. Epub 2009 Feb 27.</citation>
    <PMID>19247375</PMID>
  </reference>
  <reference>
    <citation>Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2010 Mar;51(3):836-45. doi: 10.1002/hep.23380.</citation>
    <PMID>20041405</PMID>
  </reference>
  <reference>
    <citation>Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009 Jun 18;113(25):6411-8. doi: 10.1182/blood-2008-07-170589. Epub 2009 Feb 11.</citation>
    <PMID>19211935</PMID>
  </reference>
  <reference>
    <citation>Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, Radmacher MD, Li C, Whitman SP, Mishra A, Stauffer N, Eiring AM, Briesewitz R, Baiocchi RA, Chan KK, Paschka P, Caligiuri MA, Byrd JC, Croce CM, Bloomfield CD, Perrotti D, Garzon R, Marcucci G. Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell. 2010 Apr 13;17(4):333-47. doi: 10.1016/j.ccr.2010.03.008.</citation>
    <PMID>20385359</PMID>
  </reference>
  <reference>
    <citation>Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME. Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem. 2010 Aug 1;110(5):1155-64. doi: 10.1002/jcb.22630.</citation>
    <PMID>20564213</PMID>
  </reference>
  <reference>
    <citation>Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY, Yang MH. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res. 2010 Sep 15;16(18):4561-71. doi: 10.1158/1078-0432.CCR-10-0593. Epub 2010 Sep 7.</citation>
    <PMID>20823140</PMID>
  </reference>
  <reference>
    <citation>Lin T, Ponn A, Hu X, Law BK, Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene. 2010 Sep 2;29(35):4896-904. doi: 10.1038/onc.2010.234. Epub 2010 Jun 21.</citation>
    <PMID>20562920</PMID>
  </reference>
  <reference>
    <citation>Lan L, Han H, Zuo H, Chen Z, Du Y, Zhao W, Gu J, Zhang Z. Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis. Int J Cancer. 2010 Jan 1;126(1):53-64. doi: 10.1002/ijc.24641.</citation>
    <PMID>19521958</PMID>
  </reference>
  <reference>
    <citation>Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Daidone MG, Bicciato S, Piccolo S. A MicroRNA targeting dicer for metastasis control. Cell. 2010 Jun 25;141(7):1195-207. doi: 10.1016/j.cell.2010.05.017.</citation>
    <PMID>20603000</PMID>
  </reference>
  <reference>
    <citation>Parra M, Verdin E. Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol. 2010 Aug;10(4):454-60. doi: 10.1016/j.coph.2010.04.004. Epub 2010 May 4. Review.</citation>
    <PMID>20447866</PMID>
  </reference>
  <results_reference>
    <citation>Yang MH, Chiang WC, Chou TY, Chang SY, Chen PM, Teng SC, Wu KJ. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res. 2006 Jan 15;12(2):507-15.</citation>
    <PMID>16428493</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol. 2010 Oct;12(10):982-92. doi: 10.1038/ncb2099. Epub 2010 Sep 5.</citation>
    <PMID>20818389</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang MH, Wu KJ. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle. 2008 Jul 15;7(14):2090-6. Epub 2008 May 21.</citation>
    <PMID>18635960</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008 Mar;10(3):295-305. doi: 10.1038/ncb1691. Epub 2008 Feb 24.</citation>
    <PMID>18297062</PMID>
  </results_reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>August 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2013</study_first_posted>
  <last_update_submitted>September 13, 2013</last_update_submitted>
  <last_update_submitted_qc>September 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Head-and-Neck squamous cell carcinoma (HNSCC)</keyword>
  <keyword>epithelial-mesenchymal transition (EMT)</keyword>
  <keyword>microRNA29</keyword>
  <keyword>Twist1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

